Planning for Success, Addressing Quality Early for Gene Therapies

Maribeth Janke, Ph.D.,Global Product Manager of Gene Therapy for Catalent Pharma Solutions explains the trend towards gene therapies while predicting solutions and challenges associated with this new drug class - and notes why partnering with a leader in the space is key.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: